GlassScriptPhysician profile
Ronald J Philipp
NPI 1932120771
$1,153.54
in general payments reported to CMS, 2019-2025
16 companies · $319 in 2025
The $319 reported for 2025 was more than what a typical Geriatric Medicine (Family Medicine) provider received nationally (typical 2025 total: $119).
See the full distribution for Geriatric Medicine (Family Medicine)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $225 · 2020: $34.26 · 2021: $258 · 2022: $156 · 2023: $78.07 · 2024: $82.74 · 2025: $319.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $480.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $479.74 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Teva Pharmaceuticals USA, INC. | $219.91 | 2024-2025 | Austedo Xr, Austedo Xr |
| Sunovion Pharmaceuticals INC. | $158.03 | 2019-2020 | |
| Astrazeneca Pharmaceuticals LP | $133.64 | 2021-2023 | Breztri |
| Neurocrine Biosciences, INC. | $126.68 | 2022-2025 | |
| Ucb, INC. | $111.49 | 2025 | Nayzilam, Briviact |
| Avanir Pharmaceuticals, INC. | $65.32 | 2020-2021 | |
| Sun Pharmaceutical Industries INC. | $65.09 | 2021 | |
| Janssen Pharmaceuticals, INC | $58.11 | 2019-2021 | |
| Acadia Pharmaceuticals INC | $42.97 | 2019-2022 | |
| Sumitomo Pharma America, INC. | $41.34 | 2023 | Gemtesa |
| Vanda Pharmaceuticals INC. | $33.44 | 2022 | |
| Dexcom, INC. | $23.92 | 2023 | Dexcom G6 Transmitter |
| Otsuka America Pharmaceutical, INC. | $22.02 | 2024 | Rexulti |
| Astellas Pharma US INC | $20.09 | 2019 | |
| Urovant Sciences INC | $19.97 | 2022 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Scilex Pharmaceuticals INC. | $11.52 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ronald Philipp listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.